Elevidys News, Researches and Articles

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Latest Articles

Fn14 Protein May Protect Muscle Stem Cells, Offering Promise for Development of Duchenne Treatments

Research March 27, 2025 0

For millions of people, losing muscle means losing their...

During Wave, Dyne, Regenxbio, Genethon and Others Plan to File FDA Application, Potential Safety Issues in Duchenne Worry Patients

Editorials March 27, 2025 0

Duchenne muscular dystrophy is one of the therapy areas...

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks...

Press Releases March 26, 2025 0

Wave Life Sciences, a clinical-stage biotechnology company focused on...

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Approved Treatments December 26, 2024 5

A genetic condition known as Duchenne muscular dystrophy (DMD)...

What is Duvyzat (Givinostat)?

Approved Treatments October 13, 2024 1

For individuals with Duchenne muscular dystrophy (DMD), adults and...

Cures of Duchenne (List of All Researches)

Research September 20, 2024 14

Dystrophin Gene Therapy MechanismCompanyDrugStatus Micro-dystrophin Gene Replacement Sarepta TherapeuticsElevidys/SRP-9001ApprovedMicro-dystrophin Gene ReplacementPfizerPF-06939926DiscontinuedMicro-dystrophin Gene...

Elevidys

Must Read

AlltRNA’s Engineered tRNA Technology Could Offer Hope for Nonsense Mutations

European Clinical Trial Map Launched

Clinical Trials Review of Elevidys Gene Therapy: Is Elevidys Cost Worthy?